Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Curaleaf Holdings Inc T.CURA

Alternate Symbol(s):  CURLF

Curaleaf Holdings, Inc. is an international provider of consumer cannabis products. The Company and its brands, including Curaleaf, Select, Grassroots, JAMS, Find and Zero Proof provide selection and accessibility across the medical and adult use markets. It operates in approximately 17 states and owns and operates 147 dispensaries and 21 cultivation sites with a focus on states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York and Pennsylvania. It cultivates, processes, markets and/or dispenses a range of permitted cannabis products across its operating markets, including flower and pre-rolls, dry-herb vaporizer cartridges, concentrates for vaporizing such as pre-filled vaporizer cartridges and disposable vaporizer pens, concentrates for dabbing, such as mints, topical balms and lotions, tinctures, lozenges, capsules and edibles. Through Curaleaf International Holdings Limited, it has a supply and distribution network throughout the European market.


TSX:CURA - Post by User

Comment by blackspade799on Sep 26, 2024 10:53am
84 Views
Post# 36242176

RE:Boris Jordan’s interview worth re reading

RE:Boris Jordan’s interview worth re reading
Should SC3 drag out which most are expecting, CURA is already in deep discussions with multiple partners which is expected to be a multi Billion dollar deal similar to the one Canopy did with Constellation Brands. A FSE listing also in play which will help build out CURAs current 20-25% market ownership in Germany (CURA is pushing for 60-80% ownership), M&As are in play in Germany. A delay in SC3 and NO on3 in FL will fast track our plays in the EU and Asia. The best play for CURA imo would be if SC3 and NOon3 play out. Our U.S. Hemp market will continue to grow and so will UK, Germany, Poland. Boris is always two three moves ahead. LETS GO CURA!! ;)   
<< Previous
Bullboard Posts
Next >>